Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical usefulness of liquid biopsy in metastatic breast cancer (mBC)

Type: Expression of concern
Notice date: 5/18/2021 0:00
Journal: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Publisher: American Society of Clinical Oncology
Notice DOI: 10.1200/jco.2021.39.15_suppl.1053
Original paper DOI: 10.1200/jco.2021.39.15_suppl.1053

Reasons